ESMO Preceptorship on Prostate Cancer Singapore 2016

Oncology Meeting Resources

15 Dec - 16 Dec, Singapore, Singapore

ESMO Preceptorship on Prostate Cancer

The ESMO Preceptorship on Prostate Cancer Singapore 2016 was designed for learning about fundamentals of epidemiology, natural history and diagnosis as contributing factors to heterogeneity in prostate cancer, understanding essentials in the assessment and multidisciplinary treatment of prostate cancer and learning about advances in treatment and novel targets in prostate cancer.

Presentations of the ESMO Preceptorship on Prostate Cancer Singapore 2016 are available to ESMO members according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Useful links

Presenter Presentation title Session title
A. Alip, IN Primary Hormone-Refractory Prostate Cancer Session 4 Initial Systemic Therapy
M. Khanderia, IN Metastatic Prostate Cancer Session 4 Initial Systemic Therapy
R. Kanesvaran, SG Second-Line Hormonal Therapies Session 5 Castration Resistant Prostate Cancer (CRPC)
J. Tuan, SG Isotope Therapies And Palliative Radiotherapy Session 5 Castration Resistant Prostate Cancer (CRPC)
K. Lu, TW Castration-Resistant Prostate Cancer Re-challenging Abiraterone Session 5 Castration Resistant Prostate Cancer (CRPC)
F. A. Ansari, IN Metastatic Carcinoma Prostate Session 5 Castration Resistant Prostate Cancer (CRPC)
A. Azad, AU Bone Targeting (Bisphosphonates and RANK Ligands) Session 6 Immunotherapy and Bone-Targeting
A. Azad, AU Immunotherapy and Other New Drug Targets Session 6 Immunotherapy and Bone-Targeting
J. Jamnasi, ID Metastatic Prostate Cancer Session 6 Immunotherapy and Bone-Targeting
H. Sanjay, IN Castrate Resistant Metastatic Carcinoma Prostate Session 6 Immunotherapy and Bone-Targeting